Splenic or Renal Aneurysms

Splenic Artery

Common visceral aneurysm Splenic artery aneurysms are the most common visceral artery aneurysms and are often discovered incidentally.

Report

  • Maximum diameter and location: proximal, mid, distal, or hilar.
  • True aneurysm versus pseudoaneurysm when the morphology is apparent.
  • Calcification, mural thrombus, rupture/leak, adjacent hematoma, or associated portal hypertension.
  • Pregnancy, childbearing-age context, transplant context, or symptoms when known from the history.

Management cues

  • <2 cm and asymptomatic: usually followed, often with yearly surveillance.
  • Smaller lesions may be followed at intervals of at least 1 year depending on comorbidity and life expectancy.
  • >=2 cm, enlarging, symptomatic, pseudoaneurysm, rupture concern, portal hypertension, transplant, or pregnancy-related context should prompt vascular/interventional consideration.

Renal Artery

Key threshold Many renal artery aneurysms are small and incidental; endovascular or surgical therapy is commonly considered at >=2 cm.

Report

  • Maximum diameter and whether the aneurysm involves the main renal artery, segmental branch, or hilar branch.
  • Calcification, thrombus, dissection, stenosis, renal infarct, renal atrophy, or pseudoaneurysm morphology.
  • Laterality and relationship to renal artery bifurcation or branch vessels.
  • Hypertension, hematuria, pregnancy/childbearing context, or symptoms when available.

Management cues

  • <2 cm and asymptomatic: can often be followed.
  • >=2 cm: consider vascular/interventional therapy.
  • Escalate for symptoms, growth, rupture/leak, pseudoaneurysm, renal ischemia/infarct, or clinically relevant hypertension.

Visceral Aneurysm Pearls

General rule Visceral artery aneurysms >=2 cm generally merit treatment consideration; pancreaticoduodenal aneurysms are treated regardless of size.

Higher concern

  • Pseudoaneurysm, mycotic/infectious aneurysm, traumatic or iatrogenic aneurysm.
  • Inflammatory, non-atherosclerotic, rapidly enlarging, saccular, or ruptured morphology.
  • Adjacent hematoma, active bleeding, organ ischemia, or branch vessel compromise.

Follow-up habits

  • Use CTA, MRA, or ultrasound depending on vessel location and visibility.
  • Compare directly with prior studies and report true interval growth when measurable.
  • When multiple aneurysms are present, list the largest and the highest-risk lesion.

Secondary Links